# Corebridge Financial Inc. (CRBG) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Financial Services / Insurance. Price $35.74, market value $15.9 billion.

## Valuation
- **P/E (trailing): 22.5×** (5-yr avg 6.9×, 3-yr avg 9.7×). Corebridge Financial Inc. trades at 22.5× trailing earnings, well above its own five-year average of 6.9×: investors are paying up relative to the company's past. The Financial Services median in the September 2026 study was 13.1×. Forward P/E is 6.2×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 0.8×**. Each dollar of revenue is priced at 0.8×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 2.5×**. The shares trade at 2.5× book value; book value is a meaningful part of the valuation.
- **Earnings yield: 4.4%**. The inverse of the P/E: 4.4% of the price is earned each year.

## Profitability
- **Net margin: -2.0%**. The company reported a net loss over the last twelve months.
- **Return on equity: -2.8%**. Return on equity is negative because earnings are negative.
- **Return on assets: 0.2%**. Each dollar of assets produces 0.2% of profit; low single digits are normal for banks and insurers.

## Growth
- **Revenue growth (1 yr): -1.2%** (3-yr -9.2%/yr, 5-yr 4.2%/yr). Revenue fell 1.2% over the last year, against 4.2% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -118.3%**. Earnings per share fell 118.3%, slower than revenue, so margins compressed.

## Financial health
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 2.80%** ($1.00 per share, trailing). Corebridge Financial Inc. yields 2.80%, a modest yield more typical of a growth-oriented payer.
- **Consecutive years of increases: 1**. 1 straight year of increases.
- **Shareholder yield: 21.9%**. Dividends plus net buybacks return 21.9% of the market value a year.

## Analyst view
- **Analyst consensus: buy** (12 analysts). 12 analysts cover Corebridge Financial Inc.; the consensus is buy, with an average price target of $40.42 (+13% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 10.5%** (YTD 18.4%, 3-mo 11.9%). The shares are up 10.5% over twelve months including dividends.
- **From 52-week high: -2.2%** (61.1% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 54**. An RSI of 54 is neutral.
- **Beta (1 yr): 1.27** (volatility 35%). Beta of 1.27 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CRBG · Page: https://foliofundamentals.com/stocks/crbg

Not investment advice.